PARIS and SAN DIEGO, June 12, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced that it has honored Sanofi-Aventis Recherche & Developpement (hereinafter "Sanofi") with the first Accelrys Scientific Innovation Lifecycle Leaders Award. The award, in the Life Sciences Research and Development category, recognizes Sanofi's Share Drug Discovery Data with External Partners (SHERPA) service, which is dramatically accelerating Sanofi's collaboration with external partners, addressing a key obstacle to bringing innovative new products to market faster and more efficiently.
To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/accelrys-honors-sanofi-with-inaugural-scientific-innovation-lifecycle-leaders-award-211233271.html
The award was accepted by Marie-Pierre Fialon, Data Manager Sanofi R&D, Yves Collenot, Project Manager Informatics & Solution Sanofi R&D and Joel Ducassou, Head of Solution Center Sanofi R&D, in a ceremony held June 12, 2013, at the Sanofi Research & Development Center located at Vitry-sur-Seine (Val-de-Marne area).
"With SHERPA and a joint team from Informatics & Solution and Structure Design & Informatics departments' experts offering counsel in support of scientists at any time — scientists do not need to become engaged in complex, time-consuming data management activities, but rather focus full-time on R&D. The project team is very proud to be awarded for this accomplishment," said Yves Collonot, SHERPA project manager for Sanofi.Sanofi's SHERPA service provides a generic and complete drug discovery data exchange environment for external collaboration that enables externalized multi-disciplinary teams – including scientists and representatives from information services, data management, intellectual property and alliance management – to collaborate securely in real-time. For each partnership, SHERPA offers a common data storage and collaboration solution using the cloud-based Accelrys HEOS drug research information portal. The SHERPA service includes comprehensive end-user guidelines, contract templates, technical expertise, support and training. SHERPA allows processes to evolve over time, adapting to feedback within the collaboration. This powerful combination provides a competitive advantage for R&D teams by enabling:
- Improved data management, quality and security via streamlined data exchange among internal teams and external partners
- Reduced time spent managing data and fewer errors
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts